Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545934 · ClinicalTrials.gov registry record · NA

Preventing Excessive Gestational Weight Gain in Obese Women

A NA study, sponsored by California Polytechnic State University-San Luis Obispo.

Completed
Registry status
NA
Development phase
264
Enrollment target

NCT01545934: Completed NA study, sponsored by California Polytechnic State University-San Luis Obispo.

NCT01545934 is a NA study that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 264 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545934, a NA study, has completed, sponsored by California Polytechnic State University-San Luis Obispo.

COMPLETED
Registry status
NA
Development phase
264 participants
Enrollment target

Study Summary

The purpose of this study is to study the effects of a multicomponent lifestyle intervention that includes partial meal replacements as a means to prevent excessive gestational weight gain in obese women. The primary hypothesis is that the intervention will reduce the rate of gestational weight gain compared with standard care.

Primary Outcome

Rate of gestational weight gain will be computed as difference between weights measured at study entry and gestational week 35; this difference will be divided by the number of weeks of observation during pregnancy (i.e., weeks between study entry and final pregnancy assessment). If gestational week 35 is unavailable, most proximal clinic visit weight will be used.

Interventions

  • BEHAVIORAL Lifestyle intervention

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2012-11
Est. Completion 2020-06
Phase NA

What the finished NCT01545934 record still lists

NCT01545934 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Lifestyle intervention is the first listed.

NCT01545934 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01545934 about?

NCT01545934 is a clinical study titled "Preventing Excessive Gestational Weight Gain in Obese Women". The purpose of this study is to study the effects of a multicomponent lifestyle intervention that includes partial meal replacements as a means to prevent excessive gestational weight gain in obese women. The primary hypothesis is that the intervention will reduce the rate of gestational weight gain...

What is the current status of trial NCT01545934?

This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2012-11. Estimated completion is 2020-06.

What interventions are being tested in trial NCT01545934?

The interventions under investigation include: Lifestyle intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01545934?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01545934's enrollment target sits among peer trials

264 395th of 2000 higher than 1,605 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04101669 · 264 participants · NA

    RESET System Pivotal Trial (Rev F)

  • NCT04295863 · 264 participants · Phase 1

    Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

  • NCT05220202 · 264 participants · NA

    MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

  • NCT05473013 · 264 participants · NA

    Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01545934, the US trial registry maintained by the National Library of Medicine. NCT01545934 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.